|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 28 July 2022, 10:07. The announcement is marked as price sensitive, and is 10 page(s) in length and 491.51kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 1.059% short sold according to ASIC data. It was ranked the 207th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 July 2022, 10:07 |
| Notification of cessation of securities - IMM | 14 July 2022, 17:25 |
| Immutep granted Japanese Patent for IMP761 | 6 July 2022, 8:22 |
| TACTI-002 lung cancer data to be presented at 2022 WCLC | 27 June 2022, 9:29 |
You must be logged in to post a reply.
